138 related articles for article (PubMed ID: 36332460)
1. Lennox Gastaut Syndrome - A strategic shift in diagnosis over time?
Evans NJ; Das K
Seizure; 2022 Dec; 103():68-71. PubMed ID: 36332460
[TBL] [Abstract][Full Text] [Related]
2. Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.
Nightscales R; Chen Z; Barnard S; Auvrez C; Tao G; Sivathamboo S; Bennett C; Rychkova M; D'Souza W; Berkovic SF; Nicolo JP; O'Brien TJ; Perucca P; Scheffer IE; Kwan P
Epilepsia Open; 2024 Apr; 9(2):602-612. PubMed ID: 38135919
[TBL] [Abstract][Full Text] [Related]
3. The new International League Against Epilepsy (ILAE) definition of Lennox-Gastaut syndrome: Practical implications and limitations.
Asadi-Pooya AA
J Clin Neurosci; 2023 Sep; 115():43-46. PubMed ID: 37481837
[TBL] [Abstract][Full Text] [Related]
4. Age at onset in patients with Lennox-Gastaut syndrome: Correlations with clinical manifestations.
Asadi-Pooya AA; Farazdaghi M
J Clin Neurosci; 2022 Jun; 100():138-142. PubMed ID: 35468350
[TBL] [Abstract][Full Text] [Related]
5. Efficacy analysis of oral dexamethasone in the treatment of infantile spasms and infantile spasms related Lennox-Gastaut syndrome.
Li J; Gao Y; Cao J; Cai F; Zhai X
BMC Pediatr; 2023 May; 23(1):255. PubMed ID: 37217894
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
Besag FMC; Vasey MJ; Chin RFM
Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
[TBL] [Abstract][Full Text] [Related]
7. Real-world use of the updated refractory epilepsy screening tool for Lennox-Gastaut syndrome.
Wolf SM; Boyce D; Peña P; Piña-Garza JE; Roland JJ; Thomas B; Zogejani D; McGoldrick PE
Epilepsia Open; 2024 May; ():. PubMed ID: 38726917
[TBL] [Abstract][Full Text] [Related]
8. Frontoparietal
Balfroid T; Warren AEL; Dalic LJ; Aeby A; Berlangieri SU; Archer JS
Epilepsy Res; 2023 May; 192():107131. PubMed ID: 37054522
[TBL] [Abstract][Full Text] [Related]
9. Lennox-Gastaut Syndrome: Current Treatments, Novel Therapeutics, and Future Directions.
Nelson JA; Knupp KG
Neurotherapeutics; 2023 Sep; 20(5):1255-1262. PubMed ID: 37353676
[TBL] [Abstract][Full Text] [Related]
10. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy.
Villanueva V; García-Ron A; Smeyers P; Arias E; Soto V; García-Peñas JJ; González-Alguacil E; Sayas D; Serrano-Castro P; Garces M; Hampel K; Tomás M; Lara J; de Toledo M; Barceló I; Aledo-Serrano A; Gil-Nagel A; Iacampo L; Falip M; Saiz-Diaz RA; Gómez-Ibañez A; Sopelana D; Sanchez-Larsen A; López-González FJ
Epilepsy Behav; 2022 Dec; 137(Pt A):108958. PubMed ID: 36327646
[TBL] [Abstract][Full Text] [Related]
11. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
Lo SH; Lloyd A; Marshall J; Vyas K
Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
[TBL] [Abstract][Full Text] [Related]
12. Challenges in identifying Lennox-Gastaut syndrome in adults: A case series illustrating its changing nature.
Piña-Garza JE; Chung S; Montouris GD; Radtke RA; Resnick T; Wechsler RT
Epilepsy Behav Case Rep; 2016; 5():38-43. PubMed ID: 26977407
[TBL] [Abstract][Full Text] [Related]
13. Is adjunctive Cannabidiol effective in controlling seizures for adult patients with Lennox-Gastaut Syndrome? - A single centre long term follow up study.
Elbadri M; Bose S; Elkider M; Hayton T; McCorry D; Sumangala S; Wysota B; Samarasekera S
Epilepsy Behav; 2024 Jun; 157():109904. PubMed ID: 38908033
[TBL] [Abstract][Full Text] [Related]
14. Highly purified cannabidiol improves stability and postural tone in adult patients with Lennox-Gastaut syndrome: A case series.
Calvello C; Fernandes M; Lupo C; Placidi F; Izzi F; Bianco C; Celeste MG; Mercuri NB; Liguori C
Epileptic Disord; 2023 Feb; 25(1):74-79. PubMed ID: 36946334
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal fast activity is a biomarker of treatment response in deep brain stimulation for Lennox-Gastaut syndrome.
Dalic LJ; Warren AEL; Spiegel C; Thevathasan W; Roten A; Bulluss KJ; Archer JS
Epilepsia; 2022 Dec; 63(12):3134-3147. PubMed ID: 36114808
[TBL] [Abstract][Full Text] [Related]
16. The burden of illness in Lennox-Gastaut syndrome: a systematic literature review.
Strzelczyk A; Zuberi SM; Striano P; Rosenow F; Schubert-Bast S
Orphanet J Rare Dis; 2023 Mar; 18(1):42. PubMed ID: 36859290
[TBL] [Abstract][Full Text] [Related]
17. GABA
Nwosu GI; Shen W; Zavalin K; Poliquin S; Randhave K; Flamm C; Biven M; Langer K; Kang JQ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176165
[TBL] [Abstract][Full Text] [Related]
18. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
[TBL] [Abstract][Full Text] [Related]
19. Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
Silvinato A; Floriano I; Bernardo WM
Rev Assoc Med Bras (1992); 2022; 68(10):1345-1357. PubMed ID: 36417631
[TBL] [Abstract][Full Text] [Related]
20. Long-term medical and social outcomes of patients with Lennox-Gastaut syndrome.
Asadi-Pooya AA; Bazrafshan M; Farazdaghi M
Epilepsy Res; 2021 Dec; 178():106813. PubMed ID: 34798494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
